Indomethacin decreases jejunal fluid secretion in addition to luminal release of prostaglandin E2 in patients with acute cholera
- PMID: 1612480
- PMCID: PMC1379294
- DOI: 10.1136/gut.33.5.643
Indomethacin decreases jejunal fluid secretion in addition to luminal release of prostaglandin E2 in patients with acute cholera
Abstract
Human cholera is associated with an increased luminal release of prostaglandin E2 (PGE2), but whether inhibition of increased PGE2 synthesis will reduce or control intestinal secretion is uncertain. 'Steady state' perfusions (10 ml/minute) in 12 patients with acute cholera, and repeat perfusions in nine of these patients during the convalescent phase were therefore performed using the triple lumen technique. The proximal jejunum was perfused with isotonic saline containing sodium-sulphobromophthalein as a non-absorbable marker. After intravenous administration of indomethacin (1.0 mg/kg) the jejunal net transfer of fluid and the jejunal flow rate of PGE2 were determined in 30 minute periods for 120 minutes after a 120 minute control period. Indomethacin decreased net fluid secretion (2.1 (0.3-4.2) v 4.5 (2.5-8.4) ml/hour x cm; medians, Q50 ranges, p less than 0.01) and the jejunal flow rate of PGE2 (1.5 (1.2-2.7) v 2.2 (1.4-4.9) ng/minute, p less than 0.05). The results of similar perfusion studies in 22 patients with acute cholera, used to establish the spontaneous time related change in fluid secretion, showed no significant change in net fluid transfer (3.5 (2.2-6.2) to 3.5 (2.6-11.6) ml/hour x cm, p greater than 0.25) over 240 minutes. These data provide further evidence in favour of the hypothesis that prostaglandins have a role in the cholera toxin induced intestinal fluid secretion in man.
Similar articles
-
Prostaglandin E2 is a mediator of 5-hydroxytryptamine induced water and electrolyte secretion in the human jejunum.Gut. 1988 Oct;29(10):1337-41. doi: 10.1136/gut.29.10.1337. Gut. 1988. PMID: 3197980 Free PMC article.
-
Increased jejunal prostaglandin E2 concentrations in patients with acute cholera.Gut. 1985 Feb;26(2):188-93. doi: 10.1136/gut.26.2.188. Gut. 1985. PMID: 3855402 Free PMC article.
-
Effects of indomethacin on intestinal secretion, prostaglandin E and cyclic AMP: evidence against a role for prostaglandins in cholera toxin-induced secretion.Prostaglandins. 1975 Oct;10(4):581-7. doi: 10.1016/s0090-6980(75)80004-9. Prostaglandins. 1975. PMID: 172982
-
Mechanism and treatment of diarrhoea due to Vibrio cholerae and Escherichia coli: roles of drugs and prostaglandins.Dan Med Bull. 1996 Apr;43(2):173-85. Dan Med Bull. 1996. PMID: 8741209 Review.
-
Influence on intestinal secretion of eicosanoids.J Intern Med Suppl. 1990;732:137-44. doi: 10.1111/j.1365-2796.1990.tb01486.x. J Intern Med Suppl. 1990. PMID: 2166523 Review.
Cited by
-
Cloning, characterization, and chromosomal mapping of a phospholipase (lecithinase) produced by Vibrio cholerae.Infect Immun. 1997 Aug;65(8):3112-7. doi: 10.1128/iai.65.8.3112-3117.1997. Infect Immun. 1997. PMID: 9234762 Free PMC article.
-
Role of cyclooxygenase enzymes in a murine model of experimental cholera.Infect Immun. 2003 Nov;71(11):6234-42. doi: 10.1128/IAI.71.11.6234-6242.2003. Infect Immun. 2003. PMID: 14573642 Free PMC article.
-
Cholera toxin B subunit activates arachidonic acid metabolism.Infect Immun. 1999 Feb;67(2):794-9. doi: 10.1128/IAI.67.2.794-799.1999. Infect Immun. 1999. PMID: 9916092 Free PMC article.
-
Cholera toxin induces synthesis of phospholipase A2-activating protein.Infect Immun. 1996 Jun;64(6):2137-43. doi: 10.1128/iai.64.6.2137-2143.1996. Infect Immun. 1996. PMID: 8675318 Free PMC article.
-
Convective washout reduces the antidiarrheal efficacy of enterocyte surface-targeted antisecretory drugs.J Gen Physiol. 2013 Feb;141(2):261-72. doi: 10.1085/jgp.201210885. J Gen Physiol. 2013. PMID: 23359285 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical